Ken Getz, executive director of the Tufts Center for the Study of Drug Development (CSDD), will discuss the recent CSDD study which demonstrated that although we are enamored with innovations supporting clinical trial execution, the adoption process is highly inefficient and takes each company, on average, almost 6 years to put a new solution into practice. Mr. Getz will discuss the stages of the adoption process and areas that are most challenging, identify key opportunities for improvement, and highlight practices associated with more effective and efficient innovation adoption.